(Q45937708)

18 December 2017

title

Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG. (English)

1 reference

18 December 2017

author name string

A A Vo

1

1 reference

18 December 2017

M Toyoda

2

1 reference

18 December 2017

A Peng

3

1 reference

18 December 2017

S Bunnapradist

4

1 reference

18 December 2017

M Lukovsky

5

1 reference

18 December 2017

S C Jordan

6

1 reference

18 December 2017

language of work or name

English

0 references

publication date

25 July 2006

1 reference

18 December 2017

American Journal of Transplantation

published in

1 reference

18 December 2017

volume

6

1 reference

18 December 2017

issue

10

1 reference

18 December 2017

page(s)

2384-2390

1 reference

18 December 2017

Antibody-mediated organ-allograft rejection

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

National conference to assess antibody-mediated rejection in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

Intravenous immunoglobulin induction treatment in flow cytometry cross-match-positive kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

Current approaches to treatment of antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01472.X

10.1111/J.1600-6143.2006.01472.X

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

16869794

1 reference

18 December 2017